We often cite research and articles intended to provide you with valuable health information. If we list a research link in our articles, blog postings, or social media accounts to a website where we sell products or have product information, the exit disclaimer indicates that when you click a link you will leave the DiscoverCBD.com website and visit an external link. Links to any informational websites are provided solely as a service to our users. External links provide additional information that may be useful or interesting and have no affiliation to the promotion, sale and distribution of DiscoverCBD.com or its affiliated companies products. The link does not constitute an endorsement of these organizations by DiscoverCBD.com or its affiliated companies and none should be inferred.
Over the past few years, increasing public and political pressure has supported legalization of medical marijuana. One of the main thrusts in this effort has related to the treatment of refractory epilepsy—especially in children with Dravet syndrome—using cannabidiol (CBD). Despite initiatives in numerous states to at least legalize possession of CBD oil for treating epilepsy, little published evidence is available to prove or disprove the efficacy and safety of CBD in patients with epilepsy. This review highlights some of the basic science theory behind the use of CBD, summarizes published data on clinical use of CBD for epilepsy, and highlights issues related to the use of currently available CBD products.
Simply place the CBD Vape Oil in the designated tank (cartridge), turn on the vaporizer, and smoke the CBD vapor. The great thing about taking CBD vaporized is that it works very fast. The bioavailability is very high, which means that a very large part of the CBD being used is absorbed by the body. The CBD gets into the bloodstream very fast through the absorption in the lungs.
When administered alone, CBD is an effective anticonvulsant in maximal electrical shock (MES), magnesium-free, 4-aminopyridine, and audiogenic models (7, 8). Co-administration with AEDs leads to various effects; anticonvulsant effects of CBD are enhanced with phenytoin or phenobarbital but decreased with chlordiazepoxide, clonazepam, trimethadione, and ethosuximide. In a recent study using an acute pilocarpine model, although CBD administration reduced the number of animals displaying seizure activity, CBD did not appear to have any significant effect on the number of seizures per animal (7).
Numerous studies have found results that confirm the ability of marijuana to help anxiety and stress. In 2013 an Israeli study demonstrated that treatment with cannabinoids helped to control emotional responses and prevent stress-related responses for those that had experienced a traumatic experience. In 2015 a group of researchers found that cannabis treatments were effective in reducing anxiety in those suffering from PTSD.
The interest and preference for botanical remedies such as CBD oil over harsh pharmaceuticals are growing rapidly. You can read scientific research on the promise of CBD Oil at NCBI. While North America is taking the lead legalizing cannabis and hemp the rest of the world is starting to question their stance on prohibition because of the undeniable benefits. While all talk about plant-based remedies may seem very new, using cannabis/hemp tinctures as a holistic remedy is a generations-old tradition. It was very common to use tinctures of cannabis oil in the eighteenth and nineteenth centuries. We are enjoying a renaissance in ancestral health where we are open again to remedies that were all but forgotten about in the mad race to make medicines a pill offered by a faceless often unaccountable corporation.
The disturbing problem regarding the current status of cannabidiol is expressed in the same source. Institutional endeavors by the Food and Drug Administration to classify it as a drug are in its infancy. Nevertheless, this should mean that CBD could no longer be marketed as a dietary supplement, as that class of products is subject to ridiculously lax regulation. However, there are countless companies (some no larger than a newsstand, while others are listed on the stock exchange) that sell supplements containing cannabidiol (as oil, capsules, sprays, etc.) unencumbered by either state or federal authorities.
If you’re wondering what the function of the prefrontal cortex is, let us tell you. The prefrontal cortex is responsible for decision-making, attention, and other executive tasks, including motor skills. That means that when you consume THC, any of the above areas can be affected. For example, anecdotal evidence suggests that when people are “high,” they experience euphoria, time lapses, the decline in motor skills and mostly hunger.
Also listed among our low potency products is our bestselling CanChew® gum. With just 10 mg of CBD per piece of gum, it is easy to get started with CBD as a supplement, and adding more CBD to your diet is as simple as chewing another piece of gum. Another approachable product for those just starting out with CBD, CanChew® gum is a simple delivery method for getting your daily CBD.
In one survey, parents of children who suffer from treatment-resistant epilepsy and use CBD were asked about the benefits. 19 parents were included, 84% of which said that CBD reduced the frequency of seizures. Two parents said that CBD completely resolved seizures. Parents also reported improved alertness, sleep, and mood. Some side effects were drowsiness and fatigue .
Research on CBD and anxiety has generally looked at cannabis as a whole product, not as CBD as a standalone compound. Some studies suggest that it can help with anxiety: like this 2011 study that suggests CBDcan reduce social anxiety or this 2015 review that says CBD could be promising for many forms of anxiety. It’s also important to consider whether the CBD comes from the cannabis plant and therefore may include THC, a cannabinoid that for some, induces anxiety. Read our comprehensive article on CBD and anxiety, here.
The current trend in the cannabis-related area of research started in the late sixties and early seventies when products derived from cannabis (especially marijuana) were placed on the list of controlled substances in the US, under the Nixon administration. This move was retroactively interpreted as being part of the conservative reaction to the liberalizing spirit of the sixties.
People who experience psychosis may produce too much or even too little cannabinoids (from overactive dopamine receptors). CBD is milder than our internal cannabinoids and helps to re-establish a balance of cannabinoids in the brain. CBD also helps lower inflammation, which is often increased in schizophrenia. THC, on the other hand, is stronger than our internal cannabinoids (anandamide and 2-AG), this way potentially triggering psychosis [46, 48].